Journal of Cardiac Failure
Volume 16, Issue 4 , Pages 301-307 , April 2010

Relationship Between High Circulating Adiponectin With Bone Mineral Density and Bone Metabolism in Elderly Males With Chronic Heart Failure

  • Biljana Bozic, PhD

      Affiliations

    • Institute for Medical Research, Military Medical Academy, Belgrade, Serbia
    • Institute for Physiology and Biochemistry, University of Belgrade, Belgrade, Serbia
    • ,
  • Goran Loncar, MD, MSc

      Affiliations

    • Cardiology Department, Clinical Medical Center Zvezdara, Belgrade, Serbia
    • ,
  • Nenad Prodanovic, MD, PhD

      Affiliations

    • Clinic for Rheumatology and Clinical Immunology, Military Medical Academy, Belgrade, Serbia
    • ,
  • Zoran Radojicic, PhD

      Affiliations

    • Institute for Statistics, Faculty of Organizational Sciences, University of Belgrade, Belgrade, Serbia
    • ,
  • Vojkan Cvorovic, MD, MSc

      Affiliations

    • Clinical Hospital Center Zemun, University Clinical Center of Serbia, Belgrade, Serbia
    • ,
  • Sinisa Dimkovic, MD, PhD

      Affiliations

    • Cardiology Department, Clinical Medical Center Zvezdara, Belgrade, Serbia
    • ,
  • Vera Popovic-Brkic, MD, PhD, FRCP

      Affiliations

    • Institute of Endocrinology, University Clinical Center of Serbia, Belgrade, Serbia
    • Corresponding Author InformationReprint requests: Professor Vera Popovic-Brkic, MD, PhD, FRCP, Neuroendocrine Unit, Institute of Endocrinology, University Clinical Center of Serbia, Dr Subotic 13, 11000 Belgrade. Tel: +381 11. 3639702; Fax: +381 11 2685 357

Received 8 September 2009 ,Revised 11 December 2009 ,Accepted 17 December 2009.

References 

  1. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:2148–2159
  2. Okamoto H. Can adiponectin be a novel metabolic biomarker for heart failure?. Circ J. 2009;73:1012–1013
  3. Kenny AM, Boxer R, Walsh S, Hager WD. Femoral bone mineral density in patients with heart failure. Osteoporos Int. 2006;17:1420–1427
  4. Anker SD, Clark AL, Teixeira MM, Hellewell PG, Coats AJ. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol. 1999;83:612–615
  5. Zittermann A, Schleithoff SS, Koerfer R. Markers of bone metabolism in congestive heart failure. Clin Chim Acta. 2006;366:27–36
  6. Khosla S, Atkinson EJ, Riggs BL, Melton LJ. Relationship between body composition and bone mass in women. J Bone Miner Res. 1996;11:857–863
  7. Reid IR. Relationships among body mass, its components, and bone. Bone. 2002;31:547–555
  8. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res. 2005;309:99–109
  9. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res. 2006;21:1648–1656
  10. Ealey KN, Kaludjerovic J, Archer MC, Ward WE. Adiponectin is a negative regulator of bone mineral and bone strenght in growing mice. Exp Biol Med (Maywood). 2008;233:1546–1553
  11. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003;33:646–651
  12. Basurto L, Galván R, Cordova N, Saucedo R, Vargas C, Campos S, et al. Adiponectin is associated with low bone mineral density in elderly men. Eur J Endocrinol. 2009;160:289–293
  13. Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf). 2005;63:131–138
  14. Gonnelli S, Caffarelli C, Del Santo K, Cadirini A, Guerriero C, Lucani B, et al. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly man. Calcif Tissue Int. 2008;19:55–60
  15. Hamrick MW, Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporos Int. 2008;19:905–912
  16. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res. 2004;19:546–551
  17. Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R. Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone. 2001;28:113–117
  18. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  19. The Criteria Committee of the New York Heart Association Criteria for diagnosis and treatment of heart failure. Boston, MA: Little, Brown and Company; 1994;
  20. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med. 2002;166:111–117
  21. Silvestry FE, Kerber RE, Brook MM, Carroll JD, Eberman KM, Goldstein SA, et al. Echocardiography-guided interventions. J Am Soc Echocardiogr. 2009;22:213–231
  22. Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, et al. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J. 2007;71:623–630
  23. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart. 2006;92:1420–1424
  24. Jankowska EA, Jakubaszko J, Cwynar A, Majda J, Ponikowska B, Kustrzycka-Kratochwil D, et al. Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants. Eur J Heart Fail. 2009;11:28–38
  25. Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta. 2008;387:31–35
  26. Confavreux CB, Levine R, Karsent G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol. 2009;310:21–29
  27. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–469
  28. Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. Clin Endocrinol (Oxf). 2006;64:652–658
  29. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100:197–207
  30. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology. 2001;142:3546–3553
  31. Lorentzon M, Landin K, Mellström D, Ohlsson C. Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men. J Bone Miner Res. 2006;21:1871–1878
  32. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation. 2005;112:1428–1434
  33. Lamblin N, Mouquet F, Hennache B, Dagorn J, Susen S, Bauters C, et al. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J. 2005;26:2245–2250
  34. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005;16:1263–1271
  35. Kim BJ, Yu YM, Kim EN, Chung YE, Koh JM, Kim GS. Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf). 2007;67:152–158
  36. Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, Box JD, et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA. 2006;296:1353–1355
  37. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008;93:1952–1958

 Supported by Serbian Ministry of Science (grant 145019), by Merck Sharp & Dohme unrestricted educational grant and by biochemical laboratory “Zavod za laboratorijsku dijagnostiku Konzilijum” Belgrade.

PII: S1071-9164(09)01235-4

doi: 10.1016/j.cardfail.2009.12.015

Journal of Cardiac Failure
Volume 16, Issue 4 , Pages 301-307 , April 2010

Article Tools

* Image Usage & Resolution